Braveheart Bio, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. NOTABLESCHEDULE 13D/ABraveheart Bio, Inc.BRVESep 10

   Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)

   ORBIMED ADVISORS LLC, filed by

2. ROUTINE8-KBraveheart Bio, Inc.BRVESep 8

   Current report

3. NOTABLE10-QBraveheart Bio, Inc.BRVESep 8

   Quarterly report

4. NOTABLESCHEDULE 13DBraveheart Bio, Inc.BRVEAug 18

   Ownership stake disclosure by ORBIMED ADVISORS LLC

   ORBIMED ADVISORS LLC, filed by

5. ROUTINE3Braveheart Bio, Inc.BRVEAug 14

   Vineeta Agarwala, new insider at BRVE

   Vineeta Agarwala, reporting

6. NOTABLESCHEDULE 13DBraveheart Bio, Inc.BRVEAug 14

   Ownership stake disclosure by AH Bio Fund IV, L.P.

   AH Bio Fund IV, L.P., filed by

7. ROUTINESCHEDULE 13GBraveheart Bio, Inc.BRVEAug 14

   Ownership stake disclosure by Frazier Life Sciences Public Fund, L.P.

   Frazier Life Sciences Public Fund, L.P., filed by

8. ROUTINE4Braveheart Bio, Inc.BRVEAug 11

   3 insider filings

   Marc L Andreessen, insider filing for BRVE

   Show all 3

   • 4Insider filing for BRVEAug 11
   • 4Insider filing for BRVEAug 11
   • 4Insider filing for BRVEAug 11

   Marc L Andreessen, reporting · Benjamin A Horowitz, reporting · +2 more

9. ROUTINE4Braveheart Bio, Inc.BRVEAug 10

   Jiangsu Hengrui Pharmaceuticals Co., Ltd., insider filing for BRVE

   Jiangsu Hengrui Pharmaceuticals Co., Ltd., reporting

10. ROUTINE4Braveheart Bio, Inc.BRVEAug 7

    10 insider filings

    Forbion Growth III Management B.V., insider filing for BRVE

    Show all 10

    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7
    • 4Insider filing for BRVEAug 7

    Forbion Growth III Management B.V., reporting · Forbion Growth Opportunities Fund III Cooperatief U.A., reporting · +2 more

11. ROUTINE8-KBraveheart Bio, Inc.BRVEAug 7

    Current report

12. ROUTINES-8Braveheart Bio, Inc.BRVEAug 6

    Employee stock plan registration

13. ROUTINE424B4Braveheart Bio, Inc.BRVEAug 6

    Securities offering

14. ROUTINECERTBraveheart Bio, Inc.BRVEAug 6

    CERT filing

15. ROUTINEEFFECTBraveheart Bio, Inc.BRVEAug 6

    Registration declared effective

16. ROUTINE3Braveheart Bio, Inc.BRVEAug 6

    Jiangsu Hengrui Pharmaceuticals Co., Ltd., new insider at BRVE

    Jiangsu Hengrui Pharmaceuticals Co., Ltd., reporting

17. ROUTINE3Braveheart Bio, Inc.BRVEAug 5

    13 insider filings

    ORBIMED ADVISORS LLC, new insider at BRVE

    Show all 13

    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5
    • 3New insider at BRVEAug 5

    ORBIMED ADVISORS LLC, reporting · OrbiMed Capital GP IX LLC, reporting

18. ROUTINES-1MEFBraveheart Bio, Inc.BRVEAug 5

    S-1MEF filing

19. ROUTINE8-A12BBraveheart Bio, Inc.BRVEAug 3

    8-A12B filing

20. ROUTINES-1/ABraveheart Bio, Inc.BRVEJul 30

    Securities offering (amended)

Older filings on EDGAR